Suppr超能文献

雌二醇可预防脂肪堆积并克服雌性高脂肪饮食小鼠的瘦素抵抗。

Estradiol prevents fat accumulation and overcomes leptin resistance in female high-fat diet mice.

机构信息

Monash Obesity and Diabetes Institute/Department of Physiology (S.A.L., J.L.W., W.C., M.A.C., P.J.E.), Monash University, 3800 Clayton, Victoria, Australia; Department of Paediatrics (C.G-R.), Faculty of Medicine, Nursing and Health Sciences, Monash University and Monash Children's Hospital, 3168 Clayton, Victoria, Australia; and Department of Physiology (M.K.), Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran 76169-1411.

出版信息

Endocrinology. 2014 Nov;155(11):4447-60. doi: 10.1210/en.2014-1342. Epub 2014 Aug 22.

Abstract

In premenopausal and menopausal women in particular, suboptimal estrogens have been linked to the development of the metabolic syndrome as major contributors to fat accumulation. At the same time, estrogens have been described to have a role in regulating body metabolic status. We evaluated how endogenous or administered estrogens impact on the changes associated with high-fat diet (HFD) consumption in 2 different paradigms; ovarian-intact and in ovariectomized mice. When estradiol (E2) was cyclically administered to ovarian-intact HFD-fed mice for 12 weeks, animals gained significantly less weight than ovarian-intact vehicle controls (P < .01). This difference was mainly due to a reduced caloric intake but not to an increase in energy expenditure or locomotor activity. This E2 treatment regime to mice exposed to HFD was overall able to avoid the increase of visceral fat content to levels of those found in mice fed a regular chow diet. In the ovariectomized model, the main body weight and fat content reducing action of E2 was not only through decreasing food intake but also by increasing the whole-body energy expenditure, locomotor activity, and by inducing fat oxidation. Importantly, these animals became responsive to the anorexigenic effects of leptin in contrast to the vehicle-treated and the pair-fed control groups (P < .01). Further, in vitro hypothalamic secretion experiments revealed that treatment of obese mice with E2 is able to modulate the secretion of appetite-regulating neuropeptides; namely, E2 increased the secretion of the anorectic neuropeptide α-melanocyte-stimulating hormone and decreased the secretion of the orexigenic neuropetides neuropeptide Y and Agouti-related peptide. In conclusion, differences in response to E2 treatment of HFD-fed animals depend on their endogenous estrogenic status. Overall, E2 administration overcomes arcuate leptin resistance and partially prevents fat accumulation on these mice.

摘要

在绝经前和绝经后妇女中,雌激素不足与代谢综合征的发展有关,是脂肪堆积的主要原因。与此同时,雌激素被描述为在调节身体代谢状态方面发挥作用。我们评估了内源性或给予的雌激素如何影响两种不同模型中高脂肪饮食(HFD)摄入相关的变化;完整卵巢和卵巢切除的小鼠。当雌二醇(E2)周期性给予完整卵巢 HFD 喂养的小鼠 12 周时,与完整卵巢载体对照组相比,动物体重增加显著减少(P<.01)。这种差异主要是由于热量摄入减少,但不是由于能量消耗或运动活性增加。这种 E2 治疗方案使暴露于 HFD 的小鼠总体上能够避免内脏脂肪含量增加到常规饮食喂养的小鼠的水平。在卵巢切除模型中,E2 的主要体重和脂肪含量减少作用不仅通过减少食物摄入,而且通过增加全身能量消耗、运动活性和诱导脂肪氧化来实现。重要的是,与载体处理和配对喂养对照组相比,这些动物对瘦素的厌食作用变得敏感(P<.01)。此外,体外下丘脑分泌实验表明,用 E2 治疗肥胖小鼠能够调节食欲调节神经肽的分泌;即,E2 增加了厌食神经肽α-黑色素细胞刺激素的分泌,并减少了食欲肽神经肽 Y 和 Agouti 相关肽的分泌。总之,HFD 喂养动物对 E2 治疗的反应差异取决于其内源性雌激素状态。总的来说,E2 给药克服了弓状核瘦素抵抗,并部分防止了这些小鼠的脂肪堆积。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验